Post-Transplant Outcomes in Patients with Previously Treated Extrahepatic Malignancies Undergoing Living Donor Liver Transplantation

Amy Kim; Shin Hwang; Chul-Soo Ahn; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Gil-Chun Park; Woo-Hyoung Kang; Young-In Yoon; Sung-Gyu Lee

doi:10.12659/AOT.949461

30 September 2025 : Original article

Post-Transplant Outcomes in Patients with Previously Treated Extrahepatic Malignancies Undergoing Living Donor Liver Transplantation

Amy Kim

^{BDEF 1}, Shin Hwang

^{ABCDEF 1*}, Chul-Soo Ahn

^{BDE 1}, Deok-Bog Moon

^{BCE 1}, Tae-Yong Ha

^{BCD 1}, Gi-Won Song

^{BCDF 1}, Dong-Hwan Jung

^{BCF 1}, Gil-Chun Park

^{BCD 1}, Woo-Hyoung Kang

^{BCD 1}, Young-In Yoon

^{BCD 1}, Sung-Gyu Lee

^{AEF 1}

DOI: 10.12659/AOT.949461

Ann Transplant 2025; 30:e949461

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 1 Distribution of intervals between the final treatment of an extrahepatic malignancy (EHM) and living donor liver transplantation (LDLT). Lines indicate the median period with 95% confidence intervals (CI).

Back to the Article

Post-Transplant Outcomes in Patients with Previously Treated Extrahepatic Malignancies Undergoing Living Donor Liver Transplantation

Your Privacy